Search

Osman N Ozes

from San Bruno, CA
Age ~62
Get Report
Also known as:
Osman N Ozman
Phone and address:
209 Boardwalk Ave, San Bruno, CA 94066
(650) 871-4475
Related to:
Rodney Duesing, 73Craig W Jansen, 37Jamie M Duesing, 50Steven Duesing, 77Dennis Duesing, 79
Connected to:
Sabrina A Ozeta, 37Oscar A Ozete, 85Sule Ozev, 52Erhan Ozey, 73Daniel J Ozga, 65Jeffry A Ozga, 64Pawel M Ozga, 36Tasha M Ozga, 43Carrie A Ozgar, 50Ozhan Ozgenc, 53

Osman Ozes Phones & Addresses

  • 209 Boardwalk Ave, San Bruno, CA 94066 (650) 871-4475
  • 209 Boardwalk Ave #F, San Bruno, CA 94066
  • 101 Piccadilly Pl, San Bruno, CA 94066 (650) 871-4475
  • Bloomington, IN
  • Davis, CA
  • 48 Port Ocall Dr, Indianapolis, IN 46224 (317) 244-5524
  • Rutherford, NJ

Work

Company: Altay therapeutics Mar 2019 Position: Founder and chief scientific officer

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Indiana University Bloomington 1989 to 1993 Specialities: Molecular Biology

Skills

Grant Writing • Research • Biotechnology Industry • Public Speaking • Drug Discovery • Molecular and Cellular Biology • Molecular Oncology

Languages

English • Turkish

Interests

Family • Traveling • Education • Art • Science and Technology • Music • Arts and Culture • History • Health

Industries

Biotechnology

Resumes

Resumes

Osman Ozes Photo 1

Founder And Chief Scientific Officer

View page
Location:
209 Boardwalk Ave, San Bruno, CA 94066
Industry:
Biotechnology
Work:
Altay Therapeutics
Founder and Chief Scientific Officer
Akdeniz University Jun 2009 - Feb 2018
Professor
Teva Pharmaceuticals Jan 2014 - Feb 2017
Scientific Advisor
Auspex Pharmaceuticals, Inc. Jan 2014 - Feb 2017
Scientific Advisor
Link Biopharma Jan 2014 - Feb 2017
Founder and Chief Executive Officer
Education:
Indiana University Bloomington 1989 - 1993
Doctorates, Doctor of Philosophy, Molecular Biology Hacettepe University 1986 - 1989
Masters, Molecular Biology Hacettepe University 1983 - 1986
Bachelors, Bachelor of Science, Molecular Biology, Microbiology
Skills:
Grant Writing
Research
Biotechnology Industry
Public Speaking
Drug Discovery
Molecular and Cellular Biology
Molecular Oncology
Interests:
Family
Traveling
Education
Art
Science and Technology
Music
Arts and Culture
History
Health
Languages:
English
Turkish

Publications

Us Patents

Use Of Pirfenidone In Therapeutic Regimens

View page
US Patent:
20070117841, May 24, 2007
Filed:
Oct 21, 2004
Appl. No.:
10/574631
Inventors:
Osman Ozes - San Bruno CA, US
Lawrence Blatt - San Francisco CA, US
Scott Seiwert - Pacifica CA, US
International Classification:
A61K 31/47
US Classification:
514310000
Abstract:
The present invention provides methods for treating a disorder, and methods for inhibiting a stress-activated protein kinase (SAPK) in a cell in an individual, the methods generally involving administering to an individual in need thereof an effective amount of pirfenidone or a pirfenidone analog; comparing a post-treatment SAPK activity level in a biological sample from the individual with a pre-treatment SAPK activity level; and adjusting the dose of the pirfenidone or pirfenidone analog based on the results of the comparison step. The present invention provides methods for treating a disorder, and methods for inhibiting a SAPK in a cell in an individual, the methods generally involving administering to an individual in need thereof an effective amount of pirfenidone or a pirfenidone analog; comparing a second post-treatment SAPK activity level in a biological sample from the individual with a first post-treatment SAPK activity level; and adjusting the dose of the pirfenidone or pirfenidone analog based on the results of the comparison step.

High Throughput Collagen Synthesis Assay

View page
US Patent:
20080003635, Jan 3, 2008
Filed:
Jun 12, 2007
Appl. No.:
11/761500
Inventors:
Osman Ozes - San Bruno CA, US
Lawrence Blatt - San Francisco CA, US
Assignee:
InterMune, Inc. - Brisbane CA
International Classification:
C12Q 1/02
US Classification:
435029000
Abstract:
The present invention provides for a new plate-based high throughput screening of collagen synthesis wherein the collagen is left intact in the cells. The present invention also provides for collagen synthesis assay methods, methods of identifying candidate compounds which modulate collagen synthesis, and collagen synthesis assay compositions useful for modeling collagen depositions disorders, comprising idiopathic pulmonary fibrosis, liver fibrosis, renal fibrosis, heart fibrosis, rheumatoid arthritis, and atherosclerotic plaques.

Methods Of Treating Tnf-Mediated Disorders

View page
US Patent:
20080025986, Jan 31, 2008
Filed:
Jun 3, 2004
Appl. No.:
10/557647
Inventors:
Osman N. Ozes - San Bruno CA, US
Lawrence M. Blatt - San Francisco CA, US
International Classification:
A61K 39/395
A61K 31/4412
A61K 38/00
A61P 3/10
A61P 29/00
A61K 38/28
US Classification:
4241451, 514 2, 514345, 514 4
Abstract:
The present invention provides methods of treating TNF-α-mediated disorders, the methods generally involving administering to an individual in need thereof effective amounts of pirfenidone or a pirfenidone analog and a second therapeutic agent that reduces TNF-α synthesis or that reduces TNF-α binding to a TNF receptor. The present invention further provides methods for treating non-alcoholic steatohepatitis, the method generally involving administering to an individual in need thereof an effective amount of pirfenidone. The present invention further provides methods of treating end-stage or advanced Type II diabetes, the methods generally involving administering to an individual in need thereof effective amounts of pirfenidone and insulin.
Control profile
Osman N Ozes from San Bruno, CA, age ~62 Get Report